Madiha Derouazi

Fundador en

Amal Therapeutics SA

53 años

Health Technology

Consumer Services

Perfil

Madiha Derouazi is the founder of Amal Therapeutics SA, founded in 2012, serving as Chief Executive Officer & Director since its founding.
The current job is Chief Executive Officer at Switchkine SA starting in 2025.
Former jobs include Chief Executive Officer at Speransa Therapeutics GmbH and Chief Scientific Officer at AC Immune SA. Education includes graduate studies at the Technical University of Berlin and a doctorate from the Swiss Federal Institute of Technology.

Cargos activos de Madiha Derouazi

Empresas	Cargo	Inicio
Amal Therapeutics SA Amal Therapeutics SA BiotechnologyHealth Technology Operates a proprietary cell penetrating peptide platform which develops therapeutic vaccines in oncology	Fundador	03/09/2012

Todos los cargos activos de Madiha Derouazi

Antiguos cargos conocidos de Madiha Derouazi.

Empresas	Cargo	Fin
AC IMMUNE SA	Director Técnico/Científico/I+D	-

Ver el detalle de la experiencia de Madiha Derouazi.

Formación de Madiha Derouazi.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Madiha Derouazi.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
AC Immune SA AC Immune SA Pharmaceuticals: MajorHealth Technology Manufactures precision medicines for neurodegenerative diseases	Health Technology
Technical University of Berlin Technical University of Berlin Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Swiss Federal Institute of Technology Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Amal Therapeutics SA Amal Therapeutics SA BiotechnologyHealth Technology Operates a proprietary cell penetrating peptide platform which develops therapeutic vaccines in oncology	Health Technology